Boston Scientific Financial Statements Trends

BSX -- USA Stock  

USD 36.62  1.07  0.03%

This module enables investors to look at Boston Scientific various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Cost of Revenue of 1.8 B, Gross Profit of 6.4 B or Interest Expense of 245.2 M, but also many exotic indicators such as Interest Coverage of 0.4772, Long Term Debt to Equity of 0.6635 or Calculated Tax Rate of 28.0128. This module is a perfect complement to use when analyzing Boston Scientific Valuation or Volatility. It can also complement various Boston Scientific Technical models. Check also analysis of Boston Scientific Correlation with competitors.
Revenues

Boston Scientific Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.5 B16.3 B16.5 B
Decreasing
Stable
Cash and Equivalents168 M366.9 M335.6 M
Decreasing
Stable
Investments384 M285.3 M306.4 M
Increasing
Slightly volatile
Investments Current241.8 M182.8 M183.3 M
Decreasing
Stable
Investments Non Current490.8 M364.6 M355.5 M
Decreasing
Very volatile
Property Plant and Equipment Net1.3 B1.3 B1.4 B
Increasing
Very volatile
Inventory771.1 M914.4 M873.3 M
Increasing
Slightly volatile
Tax Assets575.7 M570.4 M451.1 M
Increasing
Slightly volatile
Trade and Non Trade Receivables1.1 B1.1 B1.2 B
Increasing
Stable
Trade and Non Trade Payables172.2 M188.1 M198.4 M
Increasing
Stable
Goodwill and Intangible Assets11 B11.4 B12.4 B
Decreasing
Very volatile
Total Liabilities9.4 B10.6 B10.2 B
Increasing
Slightly volatile
Shareholders Equity6.4 B5.7 B7.3 B
Decreasing
Stable
Accumulated Retained Earnings Deficit(7 B)(10.3 B)(6.8 B)
Decreasing
Slightly volatile
Accumulated Other Comprehensive Income32.3 M79.2 M11.2 M
Increasing
Slightly volatile
Current Assets1.2 B3.1 B3.1 B
Decreasing
Very volatile
Assets Non Current12.7 B13.2 B14.3 B
Decreasing
Very volatile
Current Liabilities923 M2.2 B2.1 B
Decreasing
Very volatile
Liabilities Non Current7.4 B8.4 B8 B
Increasing
Slightly volatile
Tax Liabilities1.3 B845.2 M1.2 B
Decreasing
Stable
Total Debt6.6 B5.1 B4.9 B
Increasing
Slightly volatile
Debt Current134.8 M3.5 M108.3 M
Decreasing
Stable
Debt Non Current4.4 B5.1 B4.6 B
Increasing
Slightly volatile
Shareholders Equity USD6.4 B5.7 B7.3 B
Decreasing
Stable
Cash and Equivalents USD599.5 M366.9 M371.5 M
Increasing
Very volatile
Total Debt USD4.5 B5.1 B4.7 B
Increasing
Slightly volatile

Boston Scientific Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues9.7 B6.7 B7.2 B
Increasing
Slightly volatile
Cost of Revenue1.8 B2 B2.2 B
Decreasing
Very volatile
Selling General and Administrative Expense2.3 B2.6 B2.5 B
Increasing
Slightly volatile
Research and Development Expense1.2 B1 B901.9 M
Increasing
Slightly volatile
Operating Expenses4.8 B5.1 B5.4 B
Increasing
Very volatile
Interest Expense245.2 M255.6 M274.5 M
Decreasing
Very volatile
Income Tax Expense(245.3 M)(472.6 M)(205.3 M)
Decreasing
Slightly volatile
Consolidated Income(523.8 M)(274.9 M)(627.2 M)
Increasing
Stable
Net Income670 M(274.9 M)(527.7 M)
Increasing
Stable
Net Income Common Stock(523.8 M)(274.9 M)(627.2 M)
Increasing
Stable
Weighted Average Shares1.4 B1.2 B1.3 B
Increasing
Very volatile
Weighted Average Shares Diluted1.2 B1.2 B1.3 B
Decreasing
Very volatile
Earning Before Interest and Taxes EBIT(445 M)(420.9 M)(545.6 M)
Increasing
Very volatile
Revenues USD6.3 B6.7 B7 B
Increasing
Stable
Net Income Common Stock USD(523.8 M)(274.9 M)(627.2 M)
Increasing
Stable
Earning Before Interest and Taxes USD(445 M)(420.9 M)(545.6 M)
Increasing
Very volatile
Gross Profit6.4 B4.8 B5 B
Increasing
Slightly volatile
Operating Income(454 M)(376.1 M)(604.1 M)
Increasing
Very volatile

Boston Scientific Cash Flow Statement

Trends Matrix
Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditure(296 M)(284.1 M)(246.7 M)
Decreasing
Slightly volatile
Net Cash Flow Business Acquisitions and Disposals(1.2 B)(1.6 B)(776.4 M)
Decreasing
Slightly volatile
Net Cash Flow Investment Acquisitions and Disposals24.7 M54.9 M34 M
Increasing
Stable
Net Cash Flow from Financing930.3 M1.5 B188.3 M
Increasing
Slightly volatile
Issuance Repayment of Debt Securities 1.1 B1.6 B513.2 M
Increasing
Slightly volatile
Issuance Purchase of Equity Shares1.4 M55.2 M(111.1 M)
Increasing
Stable
Net Cash Flow from Investing(1.5 B)(2 B)(1.1 B)
Decreasing
Slightly volatile
Net Cash Flow from Operations815.8 M540 M789.4 M
Decreasing
Very volatile
Effect of Exchange Rate Changes on Cash (1.9 M)(4.6 M)(2 M)
Decreasing
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents(152 M)(308.2 M)(182.7 M)
Increasing
Very volatile
Share Based Compensation99.3 M96.3 M105.2 M
Increasing
Very volatile
Depreciation Amortization and Accretion614.6 M692.1 M692.5 M
Increasing
Stable

Fundamental Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Earnings per Basic Share(0.3347)(0.207)(0.4426)
Increasing
Stable
Earnings per Diluted Share0.48(0.207)(0.3747)
Increasing
Stable
Earnings per Basic Share USD(0.3347)(0.207)(0.4426)
Increasing
Stable
Return on Average Equity0.0844(0.0425)(0.0638)
Increasing
Stable
Return on Average Assets0.0556(0.0161)(0.0268)
Increasing
Stable
Return on Invested Capital(0.02)(0.0529)(0.0648)
Increasing
Very volatile
Gross Margin0.83620.81540.7092
Increasing
Slightly volatile
Profit Margin0.0693(0.0368)(0.0734)
Increasing
Stable
EBITDA Margin0.06750.06210.0314
Increasing
Very volatile
Return on Sales(0.0461)(0.0563)(0.0702)
Increasing
Very volatile
Asset Turnover0.53690.49220.4428
Increasing
Very volatile
Enterprise Value over EBITDA38.771667.699823.8797
Increasing
Slightly volatile
Enterprise Value over EBIT895(94.3)62.1048
Increasing
Stable
Price to Earnings Ratio73.11(118)(67.7262)
Increasing
Very volatile
Sales per Share4.88045.01755.1343
Increasing
Slightly volatile
Price to Sales Ratio5.053.80422.6959
Increasing
Slightly volatile
Price to Book Value5.894.51383.0124
Increasing
Slightly volatile
Debt to Equity Ratio79.91.68217.9758
Increasing
Slightly volatile
Current Ratio0.781.28521.4108
Decreasing
Slightly volatile
Free Cash Flow per Share0.120.30250.3957
Decreasing
Stable
Book Value per Share4.78074.22645.3098
Decreasing
Slightly volatile
Tangible Assets Book Value per Share3.69783.65583.7364
Increasing
Slightly volatile
Total Assets Per Share16.923615.485114.8047
Decreasing
Slightly volatile
Cash Flow Per Share0.4940.4010.5853
Decreasing
Stable
Return on Investment(4.8028)(3.3109)(4.4433)
Decreasing
Very volatile
Operating Margin26.89(5.0294)(4.9212)
Increasing
Stable
Calculated Tax Rate28.012828.177630.7729
Decreasing
Slightly volatile
Receivables Turnover5.33395.47545.8218
Decreasing
Stable
Inventory Turnover2.92542.54732.6174
Decreasing
Slightly volatile
PPandE Turnover4.33684.49074.6957
Decreasing
Very volatile
Cash and Equivalents Turnover15.416114.85518.3742
Increasing
Very volatile
Accounts Payable Turnover40.305336.511935.4725
Decreasing
Slightly volatile
Accrued Expenses Turnover3.59263.43334.1423
Decreasing
Stable
Interest Coverage0.47720.29650.3853
Decreasing
Slightly volatile
Long Term Debt to Equity0.66350.8080.654
Increasing
Slightly volatile
Quick Ratio0.83930.75070.7384
Decreasing
Stable
Net Current Assets as percentage of Total Assets7.08736.60216.0961
Increasing
Very volatile
Revenue to Assets0.34970.37110.379
Increasing
Slightly volatile

Boston Scientific Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Earnings before Tax(769 M)(747.5 M)(832.5 M)
Increasing
Very volatile
Earnings Before Interest Taxes and Depreciation Amortization EBITDA2.6 B463.4 M365.5 M
Increasing
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization USD364.6 M463.4 M179.2 M
Increasing
Very volatile
Market Capitalization48.9 B28.5 B19.7 B
Increasing
Slightly volatile
Enterprise Value55.7 B34.9 B24.4 B
Increasing
Slightly volatile
Invested Capital9.7 B9.7 B7.7 B
Increasing
Slightly volatile
Average Equity6.5 B5.8 B7.5 B
Decreasing
Stable
Average Assets15.4 B15.7 B17.4 B
Decreasing
Very volatile
Invested Capital Average6.6 B7.2 B7.1 B
Increasing
Stable
Tangible Asset Value4.8 B4.9 B5 B
Increasing
Stable
Free Cash Flow651.6 M405.9 M566.2 M
Increasing
Very volatile
Working Capital285 M936.9 M974.8 M
Decreasing
Stable
Revenue Per Employee360.5 K343.9 K314.1 K
Increasing
Slightly volatile
Net Income Per Employee(21 K)(8.6 K)(26.6 K)
Increasing
Stable

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Boston Scientific Fundamental Drivers

Boston Scientific Corporation Fundamental Market Drivers

Short Percent Of Float0.99%
Forward Price Earnings22.35
Shares Short Prior Month10.54M
Average Daily Volume Last 10 Day6.45M
Average Daily Volume In Three Month7.6M
Date Short InterestDecember 31, 2018
Fifty Day Average35.37
Two Hundred Day Average35.55

Boston Scientific Upcoming Events

Boston Scientific Upcoming Company Events

Upcoming Quarterly ReportApril 26, 2017
Next Earnings ReportJuly 27, 2017
Check also analysis of Boston Scientific Correlation with competitors. Please also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Search macroaxis.com